Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Andrés Ferreri, MD, of IRCCS San Raffaele Hospital, Milan, Italy, describes the difficulties associated with treating high-risk patients with diffuse large B-cell lymphoma (DLBCL).
Improving the treatment landscape for DLBCL patients
